insights_auto
Why is ORX up 11,90%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,01 SEK
arrow_upward
+11,90%(+0,11) 1D
18 ნოე, 17:29:44 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,91 SEK
High
1,07 SEK
Low
0,88 SEK
Mkt. cap
352,99 მლნ.
Avg. vol.
734,04 ათ.
Volume
1,47 მლნ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,91 SEK
High
1,07 SEK
Low
0,88 SEK
Mkt. cap
352,99 მლნ.
Avg. vol.
734,04 ათ.
Volume
1,47 მლნ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
FXStreet
·
22 წუთის წინ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BeInCrypto
·
1 საათის წინ
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
TV News Check
·
1 საათის წინ
Dow Drops 561, Nasdaq Rises 102, S&P 500 Loses 17
Traders Union
·
51 წუთის წინ
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com